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Discussion
Experimental values of 2JHN, 3JHN, etc. of the scaffold sample molecules were 
obtained (Figure 3) and these data are presented in Table 1. Also indicated is the 
number of bonds between atoms resulting in each correlation peak. The resulting J
values indicate necessary coupling constant filter settings to maximize resonance, 
revealing multiple bond correlations. 
Future Work
It is hypothesized that the addition of allowing 
manipulation of the raw density matrix data of 
molecular orbitals in Spartan 106,7 will permit ab 
initio calculations, minimizing bias from 
predetermined basis sets in previous versions of 
Spartan, to permit the establishment of empirical 
criteria for setting 1H/15N HMBC coupling filters a 
priori, minimizing the number of NMR experiments 
required for structure elucidation.
Abstract
Nitrogen containing heterocyclic drugs that regulate the JAK-STAT pathway have proven therapeutic usage for a variety of disorders from hematological cancers to rheumatoid arthritis. The synthesis of these 
drugs to selectively inhibit specific JAK-STAT has become an active area of research for pharmaceutical companies. Nitrogen heterocycles are commonly hydrogen deficient, presenting challenges for their 
characterization. The method of choice to determine the structure of these novel drugs is Heteronuclear Multiple Bond Correlation (HMBC) Nuclear Magnetic Resonance (NMR) spectroscopy.  The limitation of 
this method is that it requires prior knowledge of the molecular orbital electron density of the molecule to be characterized. The NMR spectrometer must be tuned to the resonance frequencies of scalar coupled 
atom pairs multiple bonds removed from one another in order for their coupling to be observed. The problem to this trial & error approach to identify the correct coupling constants is that it requires significant & 
expensive spectrometer time. The experimentally determined HMBC NMR coupling constants shown here are being used to assess the complexity of computational ab initio electron density calculation 
necessary to a priori predict coupling constants for a range of nitrogen heterocycles.  The degree of computational prediction sophistication to obtain accurate coupling constants will then be used to minimize 
the number of HMBC experiments for this class of compounds.
Background
Since the discovery of somatic Janus kinase (JAK) 
mutations in chronic myeloproliferative neoplasms, selective 
inhibition of JAKs have been shown to provide therapeutic 
effects for myeloproliferative disorders (Figure 1).1-3
Heteronuclear Multiple Bond Correlation (HMBC) Nuclear 
Magnetic Resonance (NMR) experiments allow identification 
and characterization of molecular structures for the Janus 
kinase family member drugs (Figure 2).1,4 The long-range 
proton coupling constant obtained from analysis of an HMBC 
spectrum is used to identify the position of nitrogen atoms in 
a fused cyclic ring systems.4,5 To account for the wide range 
of CCs in heterocyclic alkaloids, it is necessary to run 
numerous 1H/15N HMBC experiments, varying CC filter 
settings and decoupler offset frequency. 15N has a relatively 
weak signal compared to 13C, and 1H/15N HMBC 
experiments can often be in excess of ten times the duration 
of a satisfactory 1H/13C HSQC run.
To minimize the number of HMBC acquisitions needed to 
obtain good data for representative compounds, accurate 
estimates for 2JHN, 3JHN, etc. are determined a priori. In 
Spartan 10TM (Wavefunction Inc., Irvine, CA), geometry 
optimized structures of fused heterocyclic alkaloids are 
assembled,6 representative of the classes of molecules 
commonly used as scaffolding for therapeutic drug 
synthesis.3,4 Single point Hartree-Fock energy calculations 
are performed using increasingly large basis sets to 
determine the minimal theoretical prediction set size required 
for agreeable results between experimental and theoretical 
outcomes for the various classes of heterocyclic scaffolds.
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Figure 1: An illustration 
of JAK2 with highlighting  
hydrophobic regions 
(yellow), H-bond acceptor 
regions (blue), H-bond 
donor regions (red), and 
favorable ligand locations 
(white dots).
Figure 3: The spectrum of 6-
bromoimidazo[1,2-a]pyrimidine 
with a peak blown up to show 
how JHN values are measured.
Results
Coupling between hydrogen and nitrogen has been 
characterized from several HMBC acquisitions. Figure 2 
shows the structure of 6-bromoimidazo[1,2-a]pyrimidine. 
Each atom is labeled for correlation to the peak it 
represents in Figure 3.  The labeling also allows the 
interpretation of which atoms within the structure are 
resonating (coupling) with one another (Table 1).
Figure 2: 6-bromoimidazo[1,2-a]pyrimidine.  
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6-bromoimidazo[1,2-a]pyrimidine
Peak (1H / 15N) (2-3)J (Hz)
4/A 3.80 ± 0.02
4/B 10.60 ± 0.02
3/A 4.29 ± 0.01
2/C 2.56 ± 0.06
1/A 1.36 ± 0.03
Table 1: Correlation peaks & observed coupling constants.
